Plasma derived medicinal products play a key and often unique role in the treatment of many acute and chronic pathologies.
Some of the pathologies treated with plasma-derived medicinal products

At international level, we are witnessing an increase in their use for:

Self-sufficiency rates of the plasma derived medicinal products
National data year 2020
Albumin
Antithrombin
Immunoglobulins for intravenous use
Factor VIII
Factor VIII / Factor von Willebrand
S/D virus-inactivated plasma
Factor IX
3-Factor Prothrombin complex concentrates
Fibrinogen
Candura F, et al. Analysis of the demand of the plasma-derived medicinal products in Italy 2020. Rome, National Institute, Rapporto Istisan 22-7 EN
*The value does not include Pentaglobin™
Plasma provided to industry 2000-2022
For monthly tracking data click here
Source:
Adapted by the CNS on data sent by the fractionation Companies, January 2022
Italian Plasma sent to the industry by category
Apheresis plasmaRecovered plasma
Source:
Adapted by the CNS on data sent by the fractionation Companies, January 2022